Skip to content
OrtaakarsuMedicine information

Source-based interaction record

Aspirin 500 mg + Cymbalta 60 mg

Aspirin 500 mg + Cymbalta 60 mg: published drug interaction record, medicine facts and reference links. Generic / active ingredient: Asetilsalisilik Asit + Duloksetin Hidroklorür.

Free preview

Essential record information

Public access

Free record overview for Aspirin 500 mg + Cymbalta 60 mg. Review the medicine identities and available reference links below; detailed interaction information is in the access section.

Aspirin 500 mg

Active ingredient / generic name
Asetilsalisilik Asit
ATC code
N02BA01 / B01AC06

Cymbalta 60 mg

Active ingredient / generic name
Duloksetin Hidroklorür
ATC code
N06AX21
Record type
Published interaction record
Record sources

Source checked:

A source check is not an independent clinical review.

Access to this record

Free preview
Medicine identities, available source links and, where available, selected low-level related interaction records.
Paid details
The selected pair’s available detailed interaction explanation, mechanism and clinical context require access to this record.

A single-page purchase unlocks this resource only. Membership provides the page allowance shown in your plan; it does not unlock every related record automatically.

  • This page only: 6.00 USD One-time payment
  • Monthly membership: 40.00 USD / month · starting price

A verified account is required. Monthly membership renews automatically with no trial period. Taxes and the final total appear in checkout.

Examples selected from real records

Selected free interaction examples

Free

These examples concern other medicine pairs involving the medicines above. They do not assess the main pair on this page.

Published related records: 193. The selection below does not represent the complete list.

No eligible low-level example is currently selected for this section. This does not mean that other interactions do not exist.

Examples selected from real records

Published records

The identity and source of these published related records are shown below. Clinical details are displayed according to your access to each record.

Important information and detailed context

Unlock important interaction details

The basic information is available above. Details such as explanations of moderate or severe interaction records, mechanisms and clinical context are available through paid access to the relevant record or your membership allowance.

The related record group also includes interactions classified as moderate or severe. Each record’s access right applies to its own details.

  • Interaction level and explanation
  • Interaction mechanism
  • Clinical context and precautions

This page only

6.00 USDOne-time payment

Permanent access to the selected resource. No subscription required.

Buy access to this page

Monthly membership

40.00 USD/ month · starting price

A monthly page allowance for your plan. Revisit pages unlocked during the same billing period.

Explore memberships

Monthly memberships renew automatically; there is no trial period. Taxes and the final total appear in checkout.

A verified account is required. Turkish and English versions of the same resource share one access right.

This information is not personal treatment advice. Discuss treatment decisions with your doctor or pharmacist.